The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration

In this study we evaluated the effect of intravitreal brolucizumab injections on choroidal thickness in patients with neovascular age-related macular degeneration (nAMD) who previously showed an incomplete response to anti-vascular endothelial growth factor treatment. A total of thirty-four eyes fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Ki Woong, Kim, Dong Ik, Hwang, Daniel Duck-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674594/
https://www.ncbi.nlm.nih.gov/pubmed/36400911
http://dx.doi.org/10.1038/s41598-022-23392-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674594/
https://www.ncbi.nlm.nih.gov/pubmed/36400911
http://dx.doi.org/10.1038/s41598-022-23392-6

Ejemplares similares